- Home
- ALT vs WNC Comparison
ALT vs WNC Comparison
Compare ALT & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | WNC |
|---|---|---|
| Founded | 1997 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.5M | 392.2M |
| IPO Year | 2005 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ALT | WNC |
|---|---|---|
| Price | $3.35 | $9.32 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $17.67 | $11.00 |
| AVG Volume (30 Days) | ★ 2.6M | 468.5K |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 3.50% |
| EPS Growth | 25.37 | ★ 179.22 |
| EPS | N/A | ★ 5.07 |
| Revenue | $41,000.00 | ★ $2,027,489,000.00 |
| Revenue This Year | N/A | $10.65 |
| Revenue Next Year | N/A | $14.06 |
| P/E Ratio | ★ N/A | $1.80 |
| Revenue Growth | ★ 105.00 | 8.81 |
| 52 Week Low | $2.87 | $6.78 |
| 52 Week High | $7.73 | $12.94 |
Technical Indicators
Market Signals| Indicator | ALT | WNC |
|---|---|---|
| Relative Strength Index (RSI) | 42.47 | 55.59 |
| Support Level | $2.87 | $8.58 |
| Resistance Level | $4.25 | $9.33 |
| Average True Range (ATR) | 0.16 | 0.36 |
| MACD | 0.05 | 0.15 |
| Stochastic Oscillator | 60.45 | 91.09 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.